Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure

Journal of Cardiology

Volumn 60, Issue 5, 2012, Pages 416-421

  Dai, Zhehao ^a   Aoki, Tatsuo ^a   Fukumoto, Yoshihiro ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic heart failure; Coronary blood flow; Perivascular fibrosis; TIMI frame count

Indexed keywords

ADULT; AORTA PRESSURE; ARTICLE; BODY MASS; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY PERIVASCULAR FIBROSIS; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART OUTPUT; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION;

AGED; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CHRONIC DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; FIBROSIS; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MICROCIRCULATION; MIDDLE AGED;

EID: 84868613300     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.06.009     Document Type: Article

References (38)

1. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., Oates J.A., Rahko P.S., Silver M.A., Stevenson L.W., Yancy C.W. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:e391-e479.
2. Kitzman D.W., Little W.C., Brubaker P.H., Anderson R.T., Hundley W.G., Marburger C.T., Brosnihan B., Morgan T.M., Stewart K.P. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002, 288:2144-2150.
3. Redfield M.M., Jacobsen S.J., Burnett J.C., Mahoney D.W., Bailey K.R., Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003, 289:194-202.
4. Miura Y., Fukumoto Y., Shiba N., Miura T., Shimada K., Iwama Y., Takagi A., Matsusaka H., Tsutsumi T., Yamada A., Kinugawa S., Asakura M., Okamatsu S., Tsutsui H., Daida H., et al. Prevalence and clinical implication of metabolic syndrome in chronic heart failure. Circ J 2010, 74:2612-2621.
5. Cleland J.G., Cohen-Solal A., Aguilar J.C., Dietz R., Eastaugh J., Follath F., Freemantle N., Gavazzi A., van Gilst W.H., Hobbs F.D., Korewicki J., Madeira H.C., Preda I., Swedberg K., Widimsky J. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002, 360:1631-1639.
6. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., Gong Y., Liu P.P. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260-269.
7. Shiba N., Watanabe J., Shinozaki T., Koseki Y., Sakuma M., Kagaya Y., Shirato K. Analysis of chronic heart failure registry in the Tohoku district: third year follow-up. Circ J 2004, 68:427-434.
8. Shiba N., Nochioka K., Miura M., Kohno H., Shimokawa H. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan-first report from the CHART-2 study. Circ J 2011, 75:823-833.
9. Neishi Y., Akasaka T., Tsukiji M., Kume T., Wada N., Watanabe N., Kawamoto T., Kaji S., Yoshida K. Reduced coronary flow reserve in patients with congestive heart failure assessed by transthoracic Doppler echocardiography. J Am Soc Echocardiogr 2005, 18:15-19.
10. Anantharam B., Janardhanan R., Hayat S., Hickman M., Chahal N., Bassett P., Senior R. Coronary flow reserve assessed by myocardial contrast echocardiography predicts mortality in patients with heart failure. Eur J Echocardiogr 2011, 12:69-75.
11. Camici P.G., Crea F. Coronary microvascular dysfunction. N Engl J Med 2007, 356:830-840.
12. Gibson C.M., Cannon C.P., Daley W.L., Dodge J.T., Alexander B., Marble S.J., McCabe C.H., Raymond L., Fortin T., Poole W.K., Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996, 93:879-888.
13. Sun H., Fukumoto Y., Ito A., Shimokawa H., Sunagawa K. Coronary microvascular dysfunction in patients with microvascular angina: analysis by TIMI frame count. J Cardiovasc Pharmacol 2005, 46:622-626.
14. Zalewski J., Zmudka K., Musialek P., Zajdel W., Pieniazek P., Kadzielski A., Przewlocki T. Detection of microvascular injury by evaluating epicardial blood flow in early reperfusion following primary angioplasty. Int J Cardiol 2004, 96:389-396.
15. Kunadian V., Harrigan C., Zorkun C., Palmer A.M., Ogando K.J., Biller L.H., Lord E.E., Williams S.P., Lew M.E., Ciaglo L.N., Buros J.L., Marble S.J., Gibson W.J., Gibson C.M. Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years. J Thromb Thrombolysis 2009, 27:316-328.
16. Aoki T., Fukumoto Y., Sugimura K., Oikawa M., Satoh K., Nakano M., Nakayama M., Shimokawa H. Prognostic impact of myocardial interstitial fibrosis in non-ischemic heart failure-comparison between preserved and reduced ejection fraction heart failure. Circ J 2011, 75:2605-2613.
17. Higashi M., Shimokawa H., Hattori T., Hiroki J., Mukai Y., Morikawa K., Ichiki T., Takahashi S., Takeshita A. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 2003, 93:767-775.
18. Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., Klocke F.J., Bonow R.O., Judd R.M. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
19. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., Bundy J., Finn J.P., Klocke F.J., Judd R.M. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
20. Nojiri A., Hongo K., Kawai M., Komukai K., Sakuma T., Taniguchi I., Yoshimura M. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy. J Cardiol 2011, 58:253-260.
21. Mohri M., Koyanagi M., Egashira K., Tagawa H., Ichiki T., Shimokawa H., Takeshita A. Angina pectoris caused by coronary microvascular spasm. Lancet 1998, 351:1165-1169.
22. Diez J., Querejeta R., Lopez B., Gonzalez A., Larman M., Martinez Ubago J.L. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002, 105:2512-2517.
23. van Heerebeek L., Hamdani N., Handoko M.L., Falcao-Pires I., Musters R.J., Kupreishvili K., Ijsselmuiden A.J., Schalkwijk C.G., Bronzwaer J.G., Diamant M., Borbely A., van der Velden J., Stienen G.J., Laarman G.J., Niessen H.W., et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008, 117:43-51.
24. Hein S., Arnon E., Kostin S., Schonburg M., Elsasser A., Polyakova V., Bauer E.P., Klovekorn W.P., Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003, 107:984-991.
25. Graham H.K., Trafford A.W. Spatial disruption and enhanced degradation of collagen with the transition from compensated ventricular hypertrophy to symptomatic congestive heart failure. Am J Physiol Heart Circ Physiol 2007, 292:H1364-H1372.
26. Watanabe S., Shite J., Takaoka H., Shinke T., Tanino Y., Otake H., Matsumoto D., Ogasawara D., Sawada T., Hirata K., Yokoyama M. Predictive importance of left ventricular myocardial stiffness for the prognosis of patients with congestive heart failure. J Cardiol 2011, 58:245-252.
27. Tanaka M., Fujiwara H., Onodera T., Wu D.J., Hamashima Y., Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 1986, 55:575-581.
28. Shirani J., Pick R., Roberts W.C., Maron B.J. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 2000, 35:36-44.
29. James T.N., Burch G.E. Blood supply of the human interventricular septum. Circulation 1958, 17:391-396.
30. Range F.T., Schafers M., Acil T., Schafers K.P., Kies P., Paul M., Hermann S., Brisse B., Breithardt G., Schober O., Wichter T. Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. Eur Heart J 2007, 28:2223-2230.
31. Hongo M., Goto T., Watanabe N., Nakatsuka T., Tanaka M., Kinoshita O., Yamada H., Okubo S., Sekiguchi M. Relation of phasic coronary flow velocity profile to clinical and hemodynamic characteristics of patients with aortic valve disease. Circulation 1993, 88:953-960.
32. Weiss M.B., Ellis K., Sciacca R.R., Johnson L.L., Schmidt D.H., Cannon P.J. Myocardial blood flow in congestive and hypertrophic cardiomyopathy: relationship to peak wall stress and mean velocity of circumferential fiber shortening. Circulation 1976, 54:484-494.
33. Yasuda S., Shimokawa H. Acute myocardial infarction: the enduring challenge for cardiac protection and survival. Circ J 2009, 73:2000-2008.
34. Kass D.A., Bronzwaer J.G., Paulus W.J. What mechanisms underlie diastolic dysfunction in heart failure?. Circ Res 2004, 94:1533-1542.
35. Fukui S., Fukumoto Y., Suzuki J., Saji K., Nawata J., Tawara S., Shinozaki T., Kagaya Y., Shimokawa H. Long-term inhibition of Rho-kinase ameliorates diastolic heart failure in hypertensive rats. J Cardiovasc Pharmacol 2008, 51:317-326.
36. Asif M., Egan J., Vasan S., Jyothirmayi G.N., Masurekar M.R., Lopez S., Williams C., Torres R.L., Wagle D., Ulrich P., Cerami A., Brines M., Regan T.J. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci USA 2000, 97:2809-2813.
37. Bickel C., Rupprecht H.J., Maimaitiming A., Welk I., Blankenberg S., Krummenauer F., Meyer J. The superiority of TIMI frame count in detecting coronary flow changes after coronary stenting compared to TIMI Flow Classification. J Invasive Cardiol 2002, 14:590-596.
38. Gibson C.M., Murphy S., Menown I.B., Sequeira R.F., Greene R., Van de Werf F., Schweiger M.J., Ghali M., Frey M.J., Ryan K.A., Marble S.J., Giugliano R.P., Antman E.M., Cannon C.P., Braunwald E. Determinants of coronary blood flow after thrombolytic administration TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol 1999, 34:1403-1412.